View Older Stories View More Recent Stories

Oct 24, 2023 02:00AM AviadoBio Announces Presentation of Promising Preclinical Safety and Biodistribution Data of its Gene Therapy Candidate AVB-101 for FTD-GRN at the Annual European Society of Gene and Cell Therapy Cong
Oct 19, 2023 12:20PM Transfix Closes $40M Series F Funding Round Led by New Enterprise Associates and G Squared
Oct 18, 2023 08:00AM Waymark Secures Additional $42M to Scale Tech-Enabled, Community-Based Care for Primary Care Providers and People Enrolled in Medicaid
Oct 16, 2023 04:00PM MBX Biosciences Presents Positive Results from Phase 1 Study of MBX 2109 in Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research Annual Meeting
Oct 13, 2023 04:18PM Form SC 13D/A SYNLOGIC, INC. Filed by: New Enterprise Associates 14, L.P.
Oct 12, 2023 09:00AM Mojo Vision Closes Successful New Series A Funding Round with $43.5M to Drive Micro-LED Development and Commercialization
Oct 10, 2023 09:54AM Pair Eyewear Announces $75M Series C Funding Round As It Touts Revenue Growth And Enhanced Automated U.S. Manufacturing
Oct 10, 2023 07:00AM AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations
Oct 9, 2023 08:00AM MBX Biosciences Doses First Participant in Phase 1/2 Clinical Trial of MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
Oct 3, 2023 08:00AM MBX Biosciences to Showcase Results from Phase 1 Study of MBX 2109 in Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research Annual Meeting
Sep 28, 2023 05:20PM Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P.
Sep 27, 2023 10:02AM Non-Alcoholic Retailer Boisson Announces New CEO; Receives New Funding From Convivialité Ventures and Connect Ventures
Sep 19, 2023 06:45AM Bright Health Group (BHG) Continues to Make Significant Progress Towards ACA Insurance Business Wind-Down
Sep 19, 2023 06:45AM Bright Health Group Continues to Make Significant Progress Towards ACA Insurance Business Wind-Down
Sep 13, 2023 08:30AM Hunt Scanlon Media to Host Private Equity and Venture Capital Recruiting Conference
Sep 11, 2023 08:00AM MBX Biosciences Announces Positive Phase 1 Multiple Ascending Dose Data for MBX 2109, a Long-Acting Parathyroid Hormone Peptide Prodrug, in Healthy Adults
Sep 6, 2023 10:48AM SafeBase Acquires Fellow Y Combinator-Backed Stacksi to Fuel Its Vision for Zero-friction Security Assessments
Sep 6, 2023 08:00AM OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
Sep 5, 2023 08:07AM Revelle Aesthetics™ Brings Cellulite Education to the Forefront in Celebration of National Cellulite Day
Aug 31, 2023 01:30AM Inventiva announces a financing of approximately €35.7 million from new and existing investors, consisting of a €30.6 million reserved capital increase and a €5.1 million issuance of royalty cer
Aug 30, 2023 09:00AM Zeal Capital Partners Welcomes Former New Enterprise Associates Healthcare Investor, Emily Zhen, as Principal
Aug 29, 2023 08:00AM MBX Biosciences to Participate in Morgan Stanley Global Healthcare Conference
Aug 23, 2023 09:00AM Modyfi launches full public beta for AI design platform, announces $7M in seed funding led by NEA
Aug 21, 2023 02:34PM Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P.
Aug 15, 2023 10:00AM Reimagined TechCrunch Disrupt 2023 Features New Stages and Return of Expanded Startup Battlefield Competition
Aug 7, 2023 08:00AM MBX Biosciences Announces U.S. FDA Clearance of IND Application for MBX 1416 for the Treatment of Post-Bariatric Hypoglycemia
Aug 7, 2023 07:16AM Ikena Oncology (IKNA) Acquires Pionyr Immunotherapeutics in All-Stock Transaction
Aug 7, 2023 07:00AM Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
Aug 7, 2023 06:45AM Bright Health Group Secures Financing to Support Operations Pending the Expected Close of California Medicare Advantage Business Sale
Aug 3, 2023 09:00AM Insurtech Startup Functional Finance Raises $8 Million to Further Expand Operational Efficiency for the Insurance Industry
Jul 26, 2023 08:00AM Nexo Therapeutics Launches With $60 Million Series A Financing
Jul 20, 2023 06:57PM Form 4 Sagimet Biosciences Inc. For: Jul 18 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Jul 20, 2023 11:16AM TEDCO Announces FY24 Board of Directors
Jul 20, 2023 07:58AM Gossamer Bio Inc. (GOSS) Announces $212M Private Placement Financing
Jul 20, 2023 07:56AM Gossamer Bio Announces $212 Million Private Placement Financing
Jul 13, 2023 07:01AM Savara (SVRA) Prices 21M Share Offering at $3/sh
Jul 13, 2023 07:00AM Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Jul 11, 2023 10:00AM NEA Welcomes Mark Hawkins as Venture Partner
Jul 11, 2023 08:00AM First U.S. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study
Jul 10, 2023 08:00AM MBX Biosciences Appoints Steven J. Prestrelski, Ph.D., M.B.A., as Chief Scientific Officer
Jul 7, 2023 06:01AM Form SC 13D/A MINERVA SURGICAL INC Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Jun 30, 2023 08:26PM Aigen Unveils the World's First AI-Driven, Solar-Powered, Agricultural Robotics Service
Jun 23, 2023 04:00PM Mirati Therapeutics (MRTX) Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director
Jun 23, 2023 04:00PM Mirati Therapeutics Appoints Industry Veteran Carol Gallagher, Pharm.D. as New Independent Director
Jun 23, 2023 02:33PM Form SC 13D/A Mirum Pharmaceuticals, Filed by: New Enterprise Associates 16, L.P.
Jun 23, 2023 02:32PM Form SC 13D/A Arcellx, Inc. Filed by: New Enterprise Associates 15, L.P.
Jun 23, 2023 09:00AM AvoMD Raises $5M to Combat Clinician Burnout With No-Code Clinical App Building Platform
Jun 22, 2023 12:00AM Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
Jun 15, 2023 04:23PM Form 4 Mirum Pharmaceuticals, For: Jun 13 Filed by: New Enterprise Associates 16, L.P.
Jun 12, 2023 12:14PM Kyber Knight Capital Launches With a $120 Million Inaugural Fund
View More Recent Stories View Older Stories